Key result
Metabolic syndrome linked to ~25% lower left atrial compliance, further impaired by concurrent hypertension.
Why the study?
The study aimed to investigate relationships between metabolic factors and left atrial dimensions and compliance, testing whether metabolic factors influence left atrial function independent of hemodynamic mechanisms.
Cohort (n=148)
No
In an apparently healthy population, metabolic syndrome and dyslipidemia independently impair left atrial compliance, which is associated with increased all-cause and cardiovascular mortality at 5 years.
Answers are grounded in this paper and cite their sources.
Metabolic syndrome may impair LA compliance and elevate mortality risk; hypothesis-generating for causality and intervention trials.
The association between left atrial (LA) impairment and cardiovascular diseases (CVD) and between dyslipidaemia and CVD are well known. The present study aims to investigate the relationships between metabolic factors and LA dimensions and compliance, as well as test the hypothesis that metabolic factors influence LA function independent from hemodynamic mechanisms. Arterial blood pressure (BP), waist and hip circumference, metabolic indices, and a complete echocardiographic assessment were obtained from 148 selected inhabitants (M/F 89/59; age 20−86 years) of Linosa Island, who had no history of CVD. At enrollment, 27.7% of the subjects met the criteria for metabolic syndrome (MetS) and 15.5% for arterial hypertension (HTN). LA compliance was reduced in subjects with MetS compared to those without (53 ± 27% vs. 71 ± 29%, p = 0.04) and was even lower (32 ± 17%, p = 0.01) in those with MetS and HTN. At multiple regression analysis, the presence of MetS independently determined LA maximal area (r = 0.56, p < 0.001), whereas systolic BP and the total cholesterol/HDL cholesterol ratio determined LA compliance (r = 0.41, p < 0.001). In an apparently healthy population with a high prevalence of MetS, dyslipidaemia seems to independently influence LA compliance. At a 5-year follow-up, LA compliance was reduced in both all-cause and CVD mortality groups, and markedly impaired in those who died of CVD. These findings may contribute to understanding the prognostic role of LA function in CVD and strengthen the need for early and accurate lipid control strategies.
No takes yet. Share an insight, caveat, or question.
Barbier et al. (2022) conducted a cohort in Metabolic syndrome (n=148). Metabolic syndrome vs. No metabolic syndrome was evaluated on Left atrial compliance (p=0.04). Metabolic syndrome was associated with reduced left atrial compliance compared to subjects without the syndrome, which was further impaired by concurrent hypertension.
Synapse has enriched 10 related papers. Consider them for comparative context: